- Demystifying Lithium Therapy—A Primer for Clinicians: Renal Issues, Part 1
In this CME article, learn more about recent developments with lithium as they relate to renal issues.
- Everything You Wanted to Know About Crazy (But Forgot to Ask Your DJ): Deconstructing Crazy Part II
Every song tells a story.
- Poll: How Are You Handling the Holidays as a Clinician?
Do you feel burnt out heading into the holidays? Tell us about it!
- Focused Ultrasound For Treatment Resistant Obsessive Compulsive Disorder Showing Promise
Patients with treatment resistant obsessive-compulsive disorder and depression may now experience some relief using focused ultrasound.
- The Talking Cure
"They don't teach the talking treatment anymore..."
- What I Didn’t Psychiatrically Understand in 2024. Did You?
Questions before the New Year…
- PTSD Diagnosis and Challenges
A panelist discusses how diagnosing posttraumatic stress disorder (PTSD) presents unique challenges due to symptom overlap with other mental health conditions, varying presentation across different populations, and the often-delayed onset of symptoms following traumatic events.
- PTSD Symptoms
A panelist discusses how posttraumatic stress disorder (PTSD) manifests through a complex web of symptoms, including intrusive memories, nightmares, hypervigilance, emotional numbness, and avoidance behaviors that significantly impact daily functioning and quality of life.
- What You Need to Know About NeuroStar Advanced TMS Therapy for Adolescents With Major Depressive Disorder
An expert shares more about the recent data on NeuroStar advanced TMS. Learn more here.
- Antipsychotic Prescriptions and Rehospitalizations in a Forensic Psychiatry Sample
A recent longitudinal, retrospective study aimed to examine antipsychotic prescribing and rehospitalization rates in a forensic psychiatric sample.
- In Memoriam: Psychiatrists Devoted to Child Mental Health
Remembering child psychiatrists…
- IV Psilocin Benzoate for Major Depressive Disorder: New Phase 2a Results
New positive topline results from an open-label phase 2a study of IV psilocin benzoate in patients with major depressive disorder showed that the treatment delivers rapid, lasting antidepressant effects for up to 3 months following a single dose.
- Offering Long-Acting Injectables to Patients Living with Bipolar I Disorder or Schizophrenia
This article is sponsored by Otsuka America Pharmaceutical, Inc. and Lundbeck, for which Dr. Ilan Melnick is a paid consultant.
- Criminal Sanctions, Psychosis, and Mortality
Researchers investigated the link between psychosis, criminal sanctions, and mortality rates following discharge from a hospital for acute psychosis.
- Submission Call: Child & Adolescent Psychiatry
Would you like to be featured in an upcoming print issue? Submit an article on child & adolescent psychiatry!
- MindMed Reaches Phase 3 in Study of Psychedelic MM120 for Generalized Anxiety Disorder
MindMed announced phase 3 study of psychedelic MM120 for Generalized Anxiety Disorder.
- Study Finds ERPOs Can Prevent Suicide by Firearms
Extreme risk protection orders may be an effective suicide prevention tool.
- Holiday Blues, Oohs, and Bad News
What are the psychological challenges of this upcoming holiday season?
- First Patient Dosed in Phase 3 Study of Psychedelic MM120 in Generalized Anxiety Disorder
MindMed announced phase 3 of a trial testing a new treatment for generalized anxiety disorder is under way.
- Heroes and Villains
Top stories from the weekend highlighted heroes and villains and underlined the need to address mental health.
- Mothers and Child Murder: How Psychiatrists Can Help in Prevention
In some cases of child murder by the mother, psychiatrists may have a critical role in prevention. Learn more here.
- PTSD Risk Factors and Changes in the Brain
A panelist discusses how posttraumatic stress disorder (PTSD) alters key brain regions, such as the amygdala and hippocampus, with genetic predisposition, severity of trauma exposure, and lack of social support serving as critical risk factors that can influence both the likelihood of developing the condition and its neurobiological impact.
- PTSD in Society
A panelist discusses how posttraumatic stress disorder (PTSD) permeates modern society at multiple levels, from individuals coping with personal trauma to collective trauma responses that shape community behaviors and social structures.